Tatsis Ourania, Director of Odyssey Therapeutics ODTX, has filed 0 purchases and 39 sales on the open market. Over the past 12 months that comes to a net sale of $5.7M. The latest trade was on 05/07.

TO

TO

Tatsis Ourania

Director

Company

Odyssey Therapeutics ODTX

First filing

23/02/03

Trades

72 trades

Buys / sales

0 / 39

12-month net buying

−$5.7M

Last trade

05/07

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	02/25	02/26	260 sh	$486.35	$126,451	−0.6%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	02/17–02/18	02/19	977 sh2 trades	$483.52avg.	$472,395.38	−2.0%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	02/13	02/18	1,500 sh	$499.99	$749,985	−3.1%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	02/11	02/12	466 sh	$460.43	$214,560.38	−0.9%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	01/07	01/09	4,500 sh	$474.99	$2,137,455	−9.6%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	25/12/03	25/12/05	4,500 sh	$449.99	$2,024,955	−8.8%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	25/03/10	25/03/12	3,242 sh	$499.99	$1,620,967.58	−6.0%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	25/03/04	25/03/06	4,058 sh	$485.49	$1,970,118.42	−6.9%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	25/02/27	25/02/28	530 sh	$475.34	$251,930.2	−0.9%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	25/02/25	25/02/26	354 sh	$480.95	$170,256.3	−0.5%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	25/02/18	25/02/19	244 sh	$455.06	$111,034.64	−0.4%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	25/02/11	25/02/12	310 sh	$459.83	$142,547.3	−0.5%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/06/03	24/06/05	2,175 sh	$460.00	$1,000,500	−4.2%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/05/30–24/05/31	24/06/03	4,600 sh2 trades	$441.99avg.	$2,033,158.5	−8.2%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/02/26	24/02/27	354 sh	$425.70	$150,697.8	−0.6%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/02/21	24/02/23	360 sh	$421.77	$151,837.2	−0.6%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/02/20	24/02/21	480 sh	$420.79	$201,979.2	−0.8%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/02/12	24/02/13	314 sh	$420.24	$131,955.36	−0.5%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	23/08/23	23/08/25	2,500 sh	$355.00	$887,500	−4.9%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	23/08/10	23/08/14	5,750 sh	$345.79	$1,988,292.5	−10.1%